AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
VITL

Vital Farms Inc. Common Stock (VITL) fair value

Consumer Defensive · Farm Products · NASDAQ · United States
$9.14-2.87%
Market cap $392MNext earnings 2026-11-03Updated Oct 23, 2026
Add earnings to calendarGoogle
Our verdict
Trades 64% below our fair value
Price
$9.14
Model fair valueConfidence: medium
$25.20
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a growth company: EV/EBITDA comparison.
ACCE opinionVital Farms Inc. Common Stock (VITL)
Fair value (2 models)
Not available
ACCE price target
$9.30
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $9.14 at the close on 23 Oct 2026, 22:00 CEST.
Models: EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
31
out of 100
Analysts
40% buy
10 covering
1-year return
-76.0%
Dividend yield
0.00%

Vital Farms Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Vital Farms sells pasture-raised shell eggs and egg products under its own brand and through private label, sourcing from a network of contracted family farms in the US. The moat is the brand and the pasture-raised claim, which has let it charge a premium that few egg producers can match, and it has built a direct relationship with a growing base of retail customers. The problem is that the premium has not held up: revenue fell 10.1% over the latest period, and operating margin is -24.2% against a gross margin of 28.1%, so costs below the gross line are swamping what the product earns. Forward P/E of 208x on a company with negative operating margin prices in a recovery that the current numbers do not yet show. At a $367M market cap with no index membership, this is a name to examine only if you have a specific view on egg pricing normalising and pasture-raised volume recovering; the score of 31/100 reflects that the bar is high.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
  • severe
    Cash burn and operating losses
    Free cash flow is -$48.2M against a $350M market cap, with an operating margin of -24.2%. Revenue fell 10.1% year over year, so the business is shrinking while losing cash.
  • high
    Heavy short interest
    Short interest stands at 29.1% of float. That level signals strong bearish conviction among traders and can produce sharp moves in either direction.
  • high
    Score collapse over 90 days
    The ACCE score fell 25 points, from 56 to 31, over 90 days. Margin (17) and value (23) are the weakest components, and quality sits at 42.
  • moderate
    Earnings growth diverges from revenue
    Earnings rose 51.3% year over year while revenue fell 10.1%, and net margin is effectively zero at +0.0%. Earnings growth from a small base is a weak signal, so check what drove it.

AI research notes

AI-assisted·How I use AIWritten Oct 21, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Five-year average revenue growth of 28.8% per year shows the business has compounded fast over a long stretch.
  • Return on invested capital of 13.4% suggests the company earns a solid return on the money put into its operations.
  • The average analyst mean price target of $12.67 sits 54.3% above the current share price, implying room for a rebound.
Why it could disappoint
  • Revenue fell 10.1% year over year, reversing the strong multi-year growth that supported the stock.
  • Free cash flow over the last twelve months was negative at -$48M, so the business is consuming cash rather than generating it.
  • A forward P/E of 208.3x means investors are paying a very high price for each dollar of expected earnings.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 3, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where VITL's valuation models land
Price
$9.14
Model fair valueConfidence: medium
$25.20
Model
Fair value
Upside
EV/EBITDA comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed40% buy · 10 covering analysts
● Strong buy 3● Buy 1● Hold 6● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+8.8%
1 month
-11.3%
3 months
-29.8%
6 months
-27.7%
YTD
-71.4%
1 year
-76.0%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$9.30first publication$9.34
9 Oct 2026, 00:00 CESTFair value$19.98$20.24$9.24
6 Oct 2026, 00:00 CESTFair value$20.24$19.80$9.06
1 Oct 2026, 00:00 CESTFair value$19.80$20.24$9.39
29 Sept 2026, 00:00 CESTFair value$20.24$19.88$9.95
26 Sept 2026, 00:00 CESTFair value$19.88$20.61$10.09
21 Sept 2026, 00:00 CESTFair value$20.61$20.33$11.99
18 Sept 2026, 00:00 CESTFair value$20.33$22.00$10.03
13 Sept 2026, 00:00 CESTFair value$22.00$22.78$9.74
10 Sept 2026, 00:00 CESTFair value$22.78$22.46$10.08

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full VITL page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth43Value23Quality42Momentum17Total31
Valuation
Trailing P/E
no data
Forward P/E
30.7x
PEG
no data
P/B
1.56x
EV / Revenue
0.7x
Book value/sh
$6.61
Enterprise value
$529M
Profitability
ROE
0.1%
FCF yield
-13.75%
ROIC
13.4%
Health and risk
Debt / equity
0.15
Dividend yield
0.00%
Beta
1.08

Price

-76.2% · 1Y

Ask anything about VITL

Answered from Vital Farms Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 50% of peers
low -202%0%high 12%
Div yieldbetter than 67% of peers
low 0.0%0.0%high 3.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
VITL Vital Farms Inc. Common Stock$9.14---0.1%4231
CAMANCHACA.SN Pes CamanchacaCLP 86.42--7.6x12.1%6174
LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)$3.60$1170% above--4.3%2723
2003.T Nitto Fuji Flour Milling Co.,Ltd.¥1957.00--21.7x6.7%5244
VFF Village Farms International Inc. Common Shares$2.71$434% below15.1x7.5%7157
AFRI Forafric Global PLC Ordinary Shares$12.07----202.2%1331
SAMI.BA San Miguel AGARS 401.00----73.0%1741

Sector report card

Where VITL ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 14, 2026
    Vital Farms Launches the "Behind Every Carton" Campaign to Show Consumers the Real Farms and Farmers Who Produce the Good Eggs Every Day
  • PR Newswire•Aug 6, 2026
    Silver Point Leads $125 Million Term Loan Financing for Vital Farms
  • Business Wire•Aug 6, 2026
    Vital Farms Reports Second Quarter 2026 Financial Results
2 more press releases · full archive on Investor+.INVESTOR
40 filings
September 2026
Sep 18
Form 4Insider transactionPeriod 2026-09-16
View on SEC →
Sep 4
Form 4Insider transactionPeriod 2026-09-02
View on SEC →
August 2026
Aug 17
8-KCurrent reportPeriod 2026-08-11
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR